Grants

Grants & Other Sponsored Projects

 

We're working to update the sponsored projects information that appears on this page. Please check back!

Title Principal Investigator Unitsort descending Sponsor Name
A Two-Cohort, Open-Label, Multicenter Phase II Trial Assessing the Efficacy and Safety of Pertuzumab Given in Combination with Tratuzumab and Vinor...
Stopeck,Alison T
Cancer Center Division
Genetech, Incorporated
Response of Human Prostate Tissue to Hypofractionated Ionizing Radiation
Sroka,Thomas C
Cancer Center Division
United States Army Medical Command
Development of an Automated In Situ Test to Perform Molecular Sub-Classification of Prostate Cancer in Standard Prostate Biopsies
Sokoloff,Mitchell H
Cancer Center Division
Ventana Medical Systems, Inc.
Phase II Trial of Vitamin D Supplementation in Individuals with Intermediate-Thickness Melanoma without Nodal Involvement
Jeter,Joanne M
Cancer Center Division
The Hope Foundation
Health-Related Quality-of-Life and Health-Care Resource Utilization Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies
Leischow,Scott J
Cancer Center Division
Nabi Biopharmaceuticals
Phase 3 Study of SGN-35 (brentuximab vedotin) and best supportive case (BSC)...residual Hodgkin Lymphoma (HL) following autologous stem cell...
Yeager,Andrew M
Cancer Center Division
Seattle Genetics, Incorporated
Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy (Proclaim)
Jeter,Joanne M
Cancer Center Division
Prometheus Labs
New Combination Therapies for Advanced Prostate Cancer Based on the Radiosensitizing Potential of 5-Azacytidine
Weterings,Eric
Cancer Center Division
United States Army Medical Research and Material Command
Physical Activity Form Processing Support
Hamilton,Lynn A
Cancer Center Division
Science Applications International Corporation
Further Investigation of CFZ anti-tumor activity in SCLC in vitro and in vivo models
Garland,Linda L
Cancer Center Division
Onyx Pharmaceuticals
An Automated Karyometric Assay to Predict Response to Drugs that Reduce the Risk of Breast Cancer
Frank,Denise H
Cancer Center Division
Vala Sciences, Incorporated
Lymphoma Research Foundation Clinical Career Development Award
Schatz,Jonathan H
Cancer Center Division
Lymphoma Research Foundation
Evaluating the Role of Mitochondrial ROS in SCC Cell Proliferation and Migration using Cybrid Model
Jandova,Jana
Cancer Center Division
Dermatology Foundation
Molecular mechanisms of centrosome amplification in cancer cells
Rogers,Gregory C
Cancer Center Division
Arizona Biomedical Research Commission
Public Health Surveillance of the Prevention of Complications of Bleeding and Clotting Disorders
Stopeck,Alison T
Cancer Center Division
University of Colorado
Phase III Colon Cancer Prevention Trial
Gerner,Eugene W
Cancer Center Division
University of California, Irvine
Multi-Modality Imaging of Window Chambers
Gmitro,Arthur F
Cancer Center Division
Arizona Biomedical Research Commission
USC Consortium: Colon Cancer Family Registry
Lance,Michael P
Cancer Center Division
University of Southern California
Establishing an International Network and Regional Network of Healthcare Providers to Treat Tobacco Dependence
Leischow,Scott J
Cancer Center Division
Mayo Clinic
Physical Activity Forms and Processing Support
Hamilton,Lynn A
Cancer Center Division
Science Applications International Corporation
Equipment and Training Grant
Iannone,Maria E
Cancer Center Division
The Hemophilia Alliance Foundation
A Randomised Multicenter, Phase III Open-Label Study of the Efficacy and Safety of Trastuzmab-MCC-DM1 vs. Capecitabine + Lapatinib in Patients with...
Stopeck,Alison T
Cancer Center Division
Genetech, Incorporated
An open label, multi-center, phase 3 study with corresponding blinded image to determine the efficacy and safety of a single intravenous injection ..
Kuo,Phillip H
Cancer Center Division
Bayer Healthcare Pharmaceuticals Incorportated
A Phase II/III, Multicenter, Partial Randomized, Open-Label Comparing prophylactic Treatment With BAY 94-9027 To On Demand Infusion
Stopeck,Alison T
Cancer Center Division
Bayer
A Phase II Randomized, Double-blind, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide with or without Deforolimus...
Ahmann,Frederick R
Cancer Center Division
Merck and Company
Development of folic acid derivatives for skin protection
Gandolfi,A Jay
Cancer Center Division
Niadyne, Incorporated
Development of an Automated in situ Test to Perform Molecular Sub-classification of Prostate Cancer in Standard Prostate Biopsies
Stratton,Steven P
Cancer Center Division
Ventana Medical Systems, Inc.
Southwest Oncology Group Operations Office Grant
Krouse,Robert S
Cancer Center Division
University of Michigan
Southwest Oncology Group Operations Office Grant
Miller,Thomas P
Cancer Center Division
University of Michigan
Regional Hemophilia Network-Mountain States
Stopeck,Alison T
Cancer Center Division
Oregon Health and Science University

Pages

UA@Work is produced by University Communications

888 N. Euclid Ave., Ste. 413 (or) 
P.O. Box 210158, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback

2018 © The Arizona Board of Regents on behalf of the University of Arizona